基本信息
文件名称:HDAC-IN-89-生命科学试剂-MCE.pdf
文件大小:850.63 KB
总页数:3 页
更新时间:2025-05-21
总字数:约6.05千字
文档摘要

Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

HDAC-IN-89

Cat.No.:HY-173330

分?式:C??H??F?N?O?S?

分?量:575.69

作?靶点:HDAC

作?通路:CellCycle/DNADamage;Epigenetics

储存?式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

?物活性HDAC-IN-89是HDAC1(IC50:0.95nM)、HDAC2(IC50:0.86nM)、HDAC3(IC50:1.06nM)和HDAC8(IC50:

4.24nM)的抑制剂。HDAC-IN-89可阻断细胞周期和诱导细胞凋亡(apoptosis)。HDAC-IN-89具有抗肿瘤活性

IC50TargetHDAC1HDAC2HDAC3HDAC8

0.95nM(IC50)0.86nM(IC50)1.06nM(IC50)4.24nM(IC50)

HDAC6

1000nM(IC50)

体外研究HDAC-IN-89(Compound12)(0-10000nM,72h)showscytotoxicityagainstbothNCI-H1975(IC50:0.57μM)

andHT-29(IC50:0.17μM)cancercells,butshowssignificantlyreducedcytotoxicityagainstbothWRL-68

(IC50:2.6μM)andHEK293(IC50:1.0μM)normalcells[1].

HDAC-IN-89(250nM-1μM,48h)inducescellcyclearrestintheG0/G1phaseofHT-29cellsand

significantlypromotesapoptosisofearlyandlatecellsatthecorrespondingconcentrations[1].

HDAC-IN-89(0-40μM)hasasmallinhibitory